These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7999402)

  • 21. Additional value of the 70-gene signature and levels of ER and PR for the prediction of outcome in tamoxifen-treated ER-positive breast cancer.
    Kok M; Koornstra RH; Mook S; Hauptmann M; Fles R; Jansen MP; Berns EM; Linn SC; Van 't Veer LJ
    Breast; 2012 Dec; 21(6):769-78. PubMed ID: 22738860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and secretion of transforming growth factor beta isoforms by primary cultures of human breast tumour fibroblasts in vitro and their modulation by tamoxifen.
    Benson JR; Wakefield LM; Baum M; Colletta AA
    Br J Cancer; 1996 Aug; 74(3):352-8. PubMed ID: 8695348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.
    Kuukasjärvi T; Kononen J; Helin H; Holli K; Isola J
    J Clin Oncol; 1996 Sep; 14(9):2584-9. PubMed ID: 8823339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
    Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of response to tamoxifen among Iraqi patients with advanced breast cancer.
    al-Alwan NA; al-Kubaisy W; al-Rawaq K
    East Mediterr Health J; 2000; 6(2-3):475-82. PubMed ID: 11556039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of estrogen and progesterone receptor determinations in advanced breast cancer. Estrogen receptor level but not progesterone receptor level correlates with response to tamoxifen.
    Bezwoda WR; Esser JD; Dansey R; Kessel I; Lange M
    Cancer; 1991 Aug; 68(4):867-72. PubMed ID: 1855186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries.
    Rhodes A; Jasani B; Balaton AJ; Miller KD
    J Clin Pathol; 2000 Apr; 53(4):292-301. PubMed ID: 10823126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer.
    Kuenen-Boumeester V; Van der Kwast TH; van Putten WL; Claassen C; van Ooijen B; Henzen-Logmans SC
    Int J Cancer; 1992 Oct; 52(4):581-4. PubMed ID: 1399140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunocytochemical detection of estrogen and progesterone receptors in 124 human breast cancers.
    Helin HJ; Helle MJ; Helin ML; Isola JJ
    Am J Clin Pathol; 1988 Aug; 90(2):137-42. PubMed ID: 2456008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women.
    Balleine RL; Earl MJ; Greenberg ML; Clarke CL
    Br J Cancer; 1999 Mar; 79(9-10):1564-71. PubMed ID: 10188907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interobserver reproducibility of immunocytochemical estrogen- and progesterone receptor status assessment in breast cancer.
    Biesterfeld S; Veuskens U; Schmitz FJ; Amo-Takyi B; Böcking A
    Anticancer Res; 1996; 16(5A):2497-500. PubMed ID: 8917341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical demonstration of growth factors, TGF-alpha, TGF-beta, IGF-I and neu oncogene product in benign and malignant human breast tissues.
    Mizukami Y; Nonomura A; Yamada T; Kurumaya H; Hayashi M; Koyasaki N; Taniya T; Noguchi M; Nakamura S; Matsubara F
    Anticancer Res; 1990; 10(5A):1115-26. PubMed ID: 1978632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study.
    Marrazzo A; Taormina P; Leonardi P; Lupo F; Filosto S
    Anticancer Res; 1995; 15(2):521-6. PubMed ID: 7763033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer.
    Thompson AM; Kerr DJ; Steel CM
    Br J Cancer; 1991 Apr; 63(4):609-14. PubMed ID: 2021547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients.
    Liu S; Chia SK; Mehl E; Leung S; Rajput A; Cheang MC; Nielsen TO
    Breast Cancer Res Treat; 2010 Jan; 119(1):53-61. PubMed ID: 19205877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple forms of TGF-beta 1 in breast tissues: a biologically active form of the small latent complex of TGF-beta 1.
    Baillie R; Coombes RC; Smith J
    Eur J Cancer; 1996 Aug; 32A(9):1566-73. PubMed ID: 8911119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increase of progesterone receptor by tamoxifen as a hormonal challenge test in breast cancer.
    Namer M; Lalanne C; Baulieu EE
    Cancer Res; 1980 May; 40(5):1750-2. PubMed ID: 7371003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study.
    Elledge RM; Green S; Pugh R; Allred DC; Clark GM; Hill J; Ravdin P; Martino S; Osborne CK
    Int J Cancer; 2000 Mar; 89(2):111-7. PubMed ID: 10754487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proportion of estrogen or progesterone receptor expressing cells in breast cancers and response to endocrine therapy.
    Honma N; Horii R; Iwase T; Saji S; Younes M; Ito Y; Akiyama F
    Breast; 2014 Dec; 23(6):754-62. PubMed ID: 25176593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oestrogen and progesterone receptor status in bone biopsy specimens from patients with breast cancer.
    Frenay M; Milano G; Formento JL; Francoual M; Moll JL; Namer M
    Eur J Cancer; 1991; 27(2):115-8. PubMed ID: 1827270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.